GT Biopharma, Inc. (GTBP) stock
GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.18−0.35 (-10.04%)
Close on Nov 17, 2026Market cap $143.45MP/E –Yield –
GT Biopharma cash
Cash and short-term investments held at the end of each period.
GT Biopharma's cash was $4.96M at Jun 30, 2026. For fiscal 2025 it was $6.81M, up 68.4% from the year before. Over ten years it grew 64.5% a year on average. The highest annual figure on record is $32.00M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.81M | +68.4% |
| FY2024 | Dec 31, 2024 | $4.04M | -71.1% |
| FY2023 | Dec 31, 2023 | $14.00M | -15.2% |
| FY2022 | Dec 31, 2022 | $16.51M | -48.4% |
| FY2021 | Dec 31, 2021 | $32.00M | +504.1% |
| FY2020 | Dec 31, 2020 | $5.30M | +18817.9% |
| FY2019 | Dec 31, 2019 | $28.00K | -53.3% |
| FY2018 | Dec 31, 2018 | $60.00K | -89.6% |
| FY2017 | Dec 31, 2017 | $576.00K | +2931.6% |
| FY2016 | Dec 31, 2016 | $19.00K | -59.6% |
| FY2015 | Dec 31, 2015 | $47.00K | -94.5% |
| FY2014 | Dec 31, 2014 | $855.00K | +1888.4% |
| FY2013 | Dec 31, 2013 | $43.00K | -65.0% |
| FY2012 | Dec 31, 2012 | $123.00K | +33.7% |
| FY2011 | Dec 31, 2011 | $92.00K | +70.4% |
| FY2010 | Dec 31, 2010 | $54.00K | -95.8% |
| FY2009 | Dec 31, 2009 | $1.29M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.96M | -6.8% |
| Q1 FY2026 | Mar 31, 2026 | $8.92M | +263.0% |
| Q4 FY2025 | Dec 31, 2025 | $6.81M | +68.4% |
| Q3 FY2025 | Sep 30, 2025 | $2.53M | -61.2% |
| Q2 FY2025 | Jun 30, 2025 | $5.32M | -42.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.46M | -74.9% |
| Q4 FY2024 | Dec 31, 2024 | $4.04M | -71.1% |
| Q3 FY2024 | Sep 30, 2024 | $6.51M | -59.3% |
| Q2 FY2024 | Jun 30, 2024 | $9.20M | -48.9% |
| Q1 FY2024 | Mar 31, 2024 | $9.80M | -50.8% |
| Q4 FY2023 | Dec 31, 2023 | $14.00M | -15.2% |
| Q3 FY2023 | Sep 30, 2023 | $16.00M | +540.0% |
| Q2 FY2023 | Jun 30, 2023 | $18.00M | +233.3% |
| Q1 FY2023 | Mar 31, 2023 | $19.90M | +172.6% |
| Q4 FY2022 | Dec 31, 2022 | $16.51M | -48.4% |
| Q3 FY2022 | Sep 30, 2022 | $2.50M | -35.9% |
| Q2 FY2022 | Jun 30, 2022 | $5.40M | -86.3% |
| Q1 FY2022 | Mar 31, 2022 | $7.30M | -73.5% |
| Q4 FY2021 | Dec 31, 2021 | $32.00M | +504.1% |
| Q3 FY2021 | Sep 30, 2021 | $3.90M | +1014.3% |
| Q2 FY2021 | Jun 30, 2021 | $39.51M | +4542.2% |
| Q1 FY2021 | Mar 31, 2021 | $27.56M | +551000.0% |
| Q4 FY2020 | Dec 31, 2020 | $5.30M | +18817.9% |
| Q3 FY2020 | Sep 30, 2020 | $350.00K | +11.8% |
| Q2 FY2020 | Jun 30, 2020 | $851.00K | +222.3% |
| Q1 FY2020 | Mar 31, 2020 | $5.00K | -90.2% |
| Q4 FY2019 | Dec 31, 2019 | $28.00K | -53.3% |
| Q3 FY2019 | Sep 30, 2019 | $313.00K | -74.6% |
| Q2 FY2019 | Jun 30, 2019 | $264.00K | -75.9% |
| Q1 FY2019 | Mar 31, 2019 | $51.00K | -98.2% |
| Q4 FY2018 | Dec 31, 2018 | $60.00K | -89.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.23M | -54.9% |
| Q2 FY2018 | Jun 30, 2018 | $1.10M | +2710.3% |
| Q1 FY2018 | Mar 31, 2018 | $2.87M | +1121.3% |
| Q4 FY2017 | Dec 31, 2017 | $576.00K | +2931.6% |
| Q3 FY2017 | Sep 30, 2017 | $2.73M | +1674.0% |
| Q2 FY2017 | Jun 30, 2017 | $39.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $235.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $19.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $154.00K | – |
See a number that looks wrong?